REGENXBIO, Inc. (RGNX)
8.84
+0.05
(+0.57%)
USD |
NASDAQ |
Mar 17, 14:34
REGENXBIO Profit Margin (Quarterly) : -221.3% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -93.07% |
| AbbVie, Inc. | 10.86% |
| Replimune Group, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
| Altimmune, Inc. | -105.2K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -95.82% |
| Return on Assets | -38.53% |
| Return on Invested Capital | -46.44% |
| Gross Profit Margin (Quarterly) | 67.71% |
| Operating Margin (Quarterly) | -190.0% |
| Return on Net Operating Assets | -99.51% |